TRT side effects: the real risks, and the monitoring that manages them

TRT is an effective therapy, but it is real medicine with real, well-documented side effects — which is exactly why it belongs under medical supervision rather than self-prescribed from a research vial. Here’s what the evidence shows actually happens, and what a good provider watches for. For what TRT is and isn’t proven to do, start with the TRT evidence guide.

The most common effect: thicker blood

The single most frequent issue with TRT is erythrocytosis — a rise in red-blood- cell count and hematocrit. A meta-analysis of 51 studies found testosterone raised hematocrit by about 3.18 percentage points on average (and hemoglobin by 0.80 g/dL).^[1] Thicker blood matters because, taken far enough, it can raise the risk of clots — which is why hematocrit is the lab most closely watched on TRT. Critically, the route changes the magnitude: a network meta-analysis of 29 trials found intramuscular testosterone raised hematocrit most, and patches least.^[2]

The fertility trade-off

This one is physiology, not a rare side effect: exogenous testosterone suppresses your own production. By supplying testosterone from outside, TRT lowers the brain’s LH and FSH signals, which reduces sperm production — an effect that is usually reversible after stopping but can be significant.^[3] For any man who may want children, this is the decisive consideration, and the reason enclomipheneis the fertility-preserving alternative (see enclomiphene vs TRT).

The TRAVERSE safety signals

Other effects — and who shouldn’t take it

Beyond those, TRT can cause acne, oily skin, fluid retention, breast tenderness, and can worsen sleep apnea. The Endocrine Society guideline also lists clear situations where TRT should notbe started: prostate or breast cancer, an elevated PSA pending evaluation, elevated hematocrit, untreated severe sleep apnea, severe urinary symptoms, uncontrolled heart failure, a recent heart attack or stroke, a clotting disorder, or a near-term desire for fertility.^[5] A legitimate provider screens for these before prescribing.

Why monitoring is the whole point

None of this makes TRT dangerous when done properly — it makes it a therapy that has to be managed. The Endocrine Society recommends tracking testosterone, hematocrit, and prostate (PSA) during treatment, with the first year being the most active monitoring period.^[5] Most clinicians also watch estradiol and a lipid panel. The practical implication: the “research peptide” model — order a vial, inject, skip the labs — strips out exactly the safety layer that makes TRT a reasonable therapy.

The honest bottom line

TRT’s side-effect profile is manageable but not trivial: it reliably thickens the blood (most with injections), suppresses fertility, and carries the TRAVERSE signals around heart rhythm, clots and kidneys — all reasons it requires real monitoring.^[1][4] Used under a clinician who screens you first and tracks your labs, those risks are largely managed; used as a self-directed shortcut, they aren’t. That’s the case for getting it through a legitimate provider — see how to get TRT and our TRT provider comparison.